ArticleScientific reports2026
Expanding the supply of human leukocytes for research by harvesting cell concentrates from Trima Accel tubing sets.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leukoreduction system (LRS) chambers from the Trima Accel apheresis platform are widely used as a convenient source of human peripheral blood mononuclear cells (PBMCs) for immunological research. However, increasing demand has prompted the search for alternative sources. Here, we investigated whether residual cell concentrates recovered from Trima Accel tubing sets, typically discarded after platelet apheresis, could serve as a substitute for concentrates obtained from LRS chambers. Paired samples from 20 healthy platelet donors were analyzed for recovered volume, cellular composition and yield, leukocyte subset distribution, and functional responsiveness. Tubing sets contained significantly greater volumes (23.04 ± 14.1 ml vs. 8.14 ± 0.97 ml) but lower leukocyte concentrations (35.19 ± 16.99 × 10³/µl vs. 147.60 ± 59.63 × 10³/µl) than LRS chambers. Absolute leukocyte numbers were slightly higher in LRS chambers. However, cell frequencies in tubing sets showed a minor enrichment of monocytes and a modest lymphocyte depletion. Detailed flow cytometry characterization further revealed comparable distributions of major leukocyte populations and T cell subsets, including naïve and memory compartments, without biologically meaningful differences in activation or differentiation markers. Importantly, PBMCs from both sources exhibited comparable functional responses following phytohemagglutinin (PHA) stimulation, including similar changes in activation marker expression and cytokine production. Short-term storage of tubing set samples for 24 h at 4 °C did not compromise cell viability. Overall, tubing sets represent a functionally equivalent and practical alternative leukocyte source for research applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.